ArticleAsian journal of urology2024

Optimal sequential therapy using tyrosine kinase inhibitors as the first-line treatment in patients with metastatic renal cell carcinoma: A nationwide multicenter study.

Jung Ki Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.